Internal mammary node irradiation in early breast cancer – target coverage and implications on dose to organs at risk
DOI:
https://doi.org/10.2340/1651-226X.2025.43716Keywords:
Breast cancer, adjuvant radiotherapy, internal mammary node, treatment planningAbstract
Purpose: Indications for radiotherapy (RT) of the internal mammary nodes (IMN) in early breast cancer vary between countries. While studies indicate benefits, IMN RT increases the dose to the heart and lungs, and the risk-benefit ratio of this treatment is debated. This study investigates how IMN RT affects dose to organs at risk (OAR) and pneumonitis incidence in a clinical setting.
Methods: This retrospective study includes breast cancer patients receiving adjuvant locoregional RT with and without IMN included in the target volume at Skåne University Hospital, Sweden, from 2018 to 2021. Treatment plans followed national dose-volume criteria, prioritizing lung and heart over IMN coverage. A total of 247 treatment plans for locoregional RT with IMN were compared to 397 without. Dose to OAR, IMN coverage and pneumonitis incidence were investigated.
Results: The mean ipsilateral lung dose increased by 2.7 Gy with IMN RT (p < 0.001), and the mean heart dose (left-sided treatment) by 0.5 Gy (p < 0.001). Both irradiated and treated volume in relation to planning target volume (PTV) increased with ~20% (p < 0.001). Desired IMN coverage was achieved in 76% of the plans, with lung dose exceeding recommended constraints as the primary reason for decreased target coverage in the remaining plans. Of the 220 patients with follow-up of ≥6 months, 2 (0.9%) were diagnosed with pneumonitis grade 2.
Interpretation: Introduction of IMN RT primarily resulted in an increased lung dose. However, rate of symptomatic pneumonitis was low. Most patients achieved desired IMN coverage using 3D-CRT, with lung dose being the limiting factor.
Downloads
References
The Swedish Cancer Society. 2025 [cited 2025 Apr 24]. Available from: https://www.cancerfonden.se/om-cancer/statistik/brostcancer
Early Breast Cancer Trialists’ Collaborative G. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Lancet. 2023;402(10416):1991–2003.
Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9.
https://doi.org/10.1200/JCO.2016.72.0722 DOI: https://doi.org/10.1200/JCO.2016.72.0722
Wennstig AK, Wadsten C, Garmo H, Fredriksson I, Blomqvist C, Holmberg L, et al. Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort. Breast Cancer Res. 2020;22(1):10.
https://doi.org/10.1186/s13058-020-1249-2 DOI: https://doi.org/10.1186/s13058-020-1249-2
Huang H, Roberson J, Hou W, Mani K, Valentine E, Ryu S, Stessin A. NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer. Radiother Oncol. 2021;154:87–92.
https://doi.org/10.1016/j.radonc.2020.09.003 DOI: https://doi.org/10.1016/j.radonc.2020.09.003
Karlsson F, Granath F, Smedby KE, Zedenius J, Branstrom R, Nilsson IL. Sarcoma of the breast: breast cancer history as etiologic and prognostic factor-A population-based case-control study. Breast Cancer Res Treat. 2020;183(3):669–75. DOI: https://doi.org/10.1007/s10549-020-05802-3
Jeba J, Isiah R, Subhashini J, Backianathan S, Thangakunam B, Christopher DJ. Radiation pneumonitis after conventional radiotherapy for breast cancer: a prospective study. J Clin Diagn Res. 2015;9(7):XC01–5.
https://doi.org/10.7860/JCDR/2015/13969.6211 DOI: https://doi.org/10.7860/JCDR/2015/13969.6211
Gregorowitsch ML, Verkooijen HM, Houweling A, Fuhler N, Koelemij R, Schoenmaeckers EJP, et al. Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients. Radiother Oncol. 2019;131:221–8. DOI: https://doi.org/10.1016/j.radonc.2018.07.006
Early Breast Cancer Trialists’ Collaborative Group. Electronic address bocoau. Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials. Lancet. 2024;404(10461):1407–18.
https://doi.org/10.1016/S0140-6736(24)01745-8 DOI: https://doi.org/10.1016/S0140-6736(24)01745-8
Alkner S, de Boniface J, Lundstedt D, Mjaaland I, Ryden L, Vikstrom J, et al. Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1–2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial. BMJ Open. 2023;13(9):e075543.
https://doi.org/10.1136/bmjopen-2023-075543 DOI: https://doi.org/10.1136/bmjopen-2023-075543
Goyal A, Mann GB, Fallowfield L, Duley L, Reed M, Dodwell D, et al. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes. BMJ Open. 2021;11(12):e054365.
https://doi.org/10.1136/bmjopen-2021-054365 DOI: https://doi.org/10.1136/bmjopen-2021-054365
Canadian Cancer Trials Group. Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT). 2018 [cited from 2025 Apr 24] Available from: https://clinicaltrials.gov/ct2/show/NCT03488693
NSABP Foundation Inc. A randomized phase III clinical trial evaluating post-mastectomy chestwall and regional nodal XRT and post-lumpectomy regional nodal XRT in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy [Internet]. 2013 [cited 2025 Apr 24]. Available from: https://clinicaltrials.gov/ct2/show/NCT01872975
Montero A, Arenas M, Aistei C. SIRARIS: survey of internal mammary radiotherapy among radiation oncologists from Italy & Spain. Clin Transl Oncol. 2025;27(4):1839–44.
https://doi.org/10.1007/s12094-024-03693-0 DOI: https://doi.org/10.1007/s12094-024-03693-0
Nielsen MH, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol. 2013;52(4):703–10.
https://doi.org/10.3109/0284186X.2013.765064 DOI: https://doi.org/10.3109/0284186X.2013.765064
Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat. 2008;107(3):379–87.
https://doi.org/10.1007/s10549-007-9561-4 DOI: https://doi.org/10.1007/s10549-007-9561-4
Thorsen LBJ, Overgaard J, Matthiessen LW, Berg M, Stenbygaard L, Pedersen AN, et al. Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the danish breast cancer group internal mammary node study. J Clin Oncol. 2022;40(36):4198–206. DOI: https://doi.org/10.1200/JCO.22.00044
Nielsen AWM, Thorsen LBJ, Ozcan D, Matthiessen LW, Maae E, Milo MLH, et al. Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study. Lancet Reg Health Eur. 2025;49:101160.
https://doi.org/10.1016/j.lanepe.2024.101160 DOI: https://doi.org/10.1016/j.lanepe.2024.101160
SweBCG – Nationells vårdprogram 2018-01-16 Version 2.0.
SBRG: Riktlinjer för volymer och teknik vid strålbehandling av bröstcancer _Version 5.
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol. 2016;118(1):205–8. DOI: https://doi.org/10.1016/j.radonc.2015.12.027
j.radonc.2015.12.027 DOI: https://doi.org/10.1088/1475-7516/2015/12/027
International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording, and reporting photon beam therapy. Bethesda (MD): ICRU; 1993.
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 [Internet]. Bethesda (MD): National Cancer Institute; 2017 [cited 2025 Apr 24]. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm
Refsgaard L, Buhl ES, Nielsen AWM, Thomsen MS, Andersen K, Jensen I, et al. Quality assurance of internal mammary node irradiation in the DBCG IMN2 study. Radiother Oncol. 2025;202:110600. DOI: https://doi.org/10.1016/j.radonc.2024.110600
Aznar MC, Duane FK, Darby SC, Wang Z, Taylor CW. Exposure of the lungs in breast cancer radiotherapy: a systematic review of lung doses published 2010–2015. Radiother Oncol. 2018;126(1):148–54.
https://doi.org/10.1016/j.radonc.2017.11.022 DOI: https://doi.org/10.1016/j.radonc.2017.11.022
Kugele M, Edvardsson A, Berg L, Alkner S, Andersson Ljus C, Ceberg S. Dosimetric effects of intrafractional isocenter variation during deep inspiration breath-hold for breast cancer patients using surface-guided radiotherapy. J Appl Clin Med Phys. 2018;19(1):25–38. DOI: https://doi.org/10.1002/acm2.12214
Wennstig AK, Wadsten C, Garmo H, Johansson M, Fredriksson I, Blomqvist C, et al. Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based study. NPJ Breast Cancer. 2021;7(1):71.
https://doi.org/10.1038/s41523-021-00280-2 DOI: https://doi.org/10.1038/s41523-021-00280-2
Grantzau T, Thomsen MS, Vaeth M, Overgaard J. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014;111(3):366–73. DOI: https://doi.org/10.1016/j.radonc.2014.05.004
Choi J, Kim YB, Shin KH, Ahn SJ, Lee HS, Park W, et al. Radiation pneumonitis in association with internal mammary node irradiation in breast cancer patients: an ancillary result from the KROG 08-06 study. J Breast Cancer. 2016;19(3):275–82.
https://doi.org/10.4048/jbc.2016.19.3.275 DOI: https://doi.org/10.4048/jbc.2016.19.3.275
Edvardsson A, Nilsson MP, Amptoulach S, Ceberg S. Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm. Radiat Oncol. 2015;10:84.
https://doi.org/10.1186/s13014-015-0375-y DOI: https://doi.org/10.1186/s13014-015-0375-y
Stowe HB, Andruska ND, Reynoso F, Thomas M, Bergom C. Heart sparing radiotherapy techniques in breast cancer: a focus on deep inspiration breath hold. Breast Cancer (Dove Med Press). 2022;14:175–86.
https://doi.org/10.2147/BCTT.S282799 DOI: https://doi.org/10.2147/BCTT.S282799
Rossi M, Viren T, Heikkila J, Seppala J, Boman E. The robustness of VMAT radiotherapy for breast cancer with tissue deformations. Med Dosim. 2021;46(1):86–93.
https://doi.org/10.1016/j.meddos.2020.09.005 DOI: https://doi.org/10.1016/j.meddos.2020.09.005
Frengen J, Vikstrom J, Mjaaland I, Funderud M, Almberg SS, Dybvik KI, Hjelstuen MHB. Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique. Acta Oncol. 2023;62(10):1169–77.
10.1080/0284186X.2023.2264488 DOI: https://doi.org/10.1080/0284186X.2023.2264488
Hanna SA, Mota BS, Moraes FY, Marta GN, Carvalho HA, Riera R. Intensity-modulated radiation therapy for early-stage breast cancer: a systematic review and meta-analysis. Sao Paulo Med J.
2024;143(1):e2023324.
https://doi.org/10.1590/1516-3180.2023.0324.r1.03072024 DOI: https://doi.org/10.1590/1516-3180.2023.0324.r1.03072024
Cartechini G, Fracchiolla F, Menegotti L, Scifoni E, La Tessa C, Schwarz M, et al. Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy. Radiat Oncol. 2020;15(1):228.
https://doi.org/10.1186/s13014-020-01671-8 DOI: https://doi.org/10.1186/s13014-020-01671-8
Lazzari G, Terlizzi A, Leo MG, Silvano G. VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: the incidental effect of low-dose bath exposure. Clin Transl Radiat Oncol. 2017;7:43–8.
https://doi.org/10.1016/j.ctro.2017.09.009 DOI: https://doi.org/10.1016/j.ctro.2017.09.009
Hare GB, Proulx GM, Lamonica DM, Stomper PC. Internal mammary lymph node (IMN) coverage by standard radiation tangent fields in patients showing IMN drainage on lymphoscintigraphy: therapeutic implications. Am J Clin Oncol. 2004;27(3):274–8.
https://doi.org/10.1097/01.coc.0000092596.03967.80 DOI: https://doi.org/10.1097/01.coc.0000092596.03967.80
Song Y, Yu T, Wang W, Li J, Sun T, Qiu P, et al. Dosimetric comparison of incidental radiation to the internal mammary nodes after breast-conserving surgery using 3 techniques-inverse intensity-modulated radiotherapy, field-in-field intensity-modulated radiotherapy, and 3-dimensional conformal radiotherapy: a retrospective clinical study. Medicine (Baltimore). 2019;98(41):e17549.
https://doi.org/10.1097/MD.0000000000017549 DOI: https://doi.org/10.1097/MD.0000000000017549
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Lovisa Berg, Jeanette Sporre, Elisabeth Kjellén, Sofie Ceberg, Elinore Wieslander, Sara Alkner
This work is licensed under a Creative Commons Attribution 4.0 International License.
